Health Affairs December 11, 2025
Editor’s Note
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Articles in this topic offer timely analyses of regulatory, legislative, and judicial developments in health policy under the Trump-Vance administration and the 119th Congress. Health Affairs Forefront alone reviews all submissions then selects, edits, and publishes them only if they meet Forefront’s editorial standards.
Medicare has announced its Initial Price Applicability Year (IPAY) 2027 drug prices, and attention has turned to how the Centers for Medicare and Medicaid Services (CMS) arrived at its determinations. In truth it is difficult to know. Congress requires Medicare negotiators to consider...
Today's Sponsors
Today's Sponsor